Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MIDAS: Valchlor With or Without Triamcinolone for Contact Dermatitis in Early Stage CTCL
NCT03380026Phase 2Completed
- Sponsor
- Rochester Skin Lymphoma Medical Group
- Start
- Dec 2017
- Primary completion
- Aug 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of triamcinolone acetonide in contact dermatitis, sponsored by Rochester Skin Lymphoma Medical Group. Started Dec 2017; status: completed.
02
Drugs
triamcinolone acetonide
03
Conditions
contact dermatitis
Beyond the preview
Go deeper on NCT03380026.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03380026.